These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35589385)

  • 21. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

  • 22. Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung Cancer.
    Ito K; Suzuki Y; Sakaguchi T; Fujiwara K; Nishii Y; Yasui H; Taguchi O; Hataji O
    JAMA Oncol; 2024 May; 10(5):648-651. PubMed ID: 38546663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
    Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
    Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of nutritional status in patients with human immunodeficiency virus infection-related lymphoma.
    Liu T; Hu R; Lv J; Luo Q; Xu L; Wang C; Liu J; Yang Z; Xu L; Liu Y
    Front Nutr; 2022; 9():1050139. PubMed ID: 36438738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.
    Neeman E; Gresham G; Ovasapians N; Hendifar A; Tuli R; Figlin R; Shinde A
    Oncologist; 2019 Dec; 24(12):e1460-e1466. PubMed ID: 31227648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer.
    Dolan RD; Daly L; Sim WMJ; Fallon M; Ryan A; McMillan DC; Laird BJ
    Clin Nutr; 2020 Sep; 39(9):2889-2895. PubMed ID: 31926762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients.
    Chen D; Wen X; Song YS; Rhee YY; Lee TH; Cho NY; Han SW; Kim TY; Kang GH
    Clin Epigenetics; 2016; 8():36. PubMed ID: 27051466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy with toripalimab for lung adenocarcinoma in a real-world patient with an Eastern Cooperative Oncology Group performance status (ECOG PS) score of 4: a case report.
    Xue Y; Zheng K; Xue J
    Ann Palliat Med; 2021 Sep; 10(9):10114-10123. PubMed ID: 34628932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
    Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
    JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study.
    Cheng CB; Zhang QX; Zhuang LP; Sun JW
    Jpn J Clin Oncol; 2020 Sep; 50(10):1141-1149. PubMed ID: 32564084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.
    Schnadig ID; Fromme EK; Loprinzi CL; Sloan JA; Mori M; Li H; Beer TM
    Cancer; 2008 Oct; 113(8):2205-14. PubMed ID: 18780322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of ECOG/WHO performance status and ASA score as a measure of functional status.
    Young J; Badgery-Parker T; Dobbins T; Jorgensen M; Gibbs P; Faragher I; Jones I; Currow D
    J Pain Symptom Manage; 2015 Feb; 49(2):258-64. PubMed ID: 24996034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of Lymphocyte-C-Reactive Protein Ratio in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study.
    Zhang H; Wang Y; Ni J; Shi H; Zhang T; Zhang Y; Guo J; Wang K; Mao W; Peng B
    Front Oncol; 2021; 11():760389. PubMed ID: 34778081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High systemic immune-inflammation index is a predictor of poor prognosis in patients with nonsmall cell lung cancer and bone metastasis.
    Xu S; Cao S; Yu Y
    J Cancer Res Ther; 2021 Dec; 17(7):1636-1642. PubMed ID: 35381733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive comparative analysis of the prognostic impact of systemic inflammation biomarkers for patients underwent cardiac surgery.
    Liu Z; Zhu G; Zhang Y; Zhang P; Zang W; Shen Z
    Front Immunol; 2023; 14():1190380. PubMed ID: 37646036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group.
    Giessen C; Graeven U; Laubender RP; Modest DP; Schulz C; Porschen R; Schmiegel W; Reinacher-Schick A; Hegewisch-Becker S; Stintzing S; Heinemann V
    Ann Oncol; 2013 Dec; 24(12):3051-5. PubMed ID: 24130263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy.
    Mei J; Sun XQ; Lin WP; Li SH; Lu LH; Zou JW; Wei W; Guo RP
    J Inflamm Res; 2021; 14():3879-3890. PubMed ID: 34408469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study.
    Utsumi M; Inagaki M; Kitada K; Tokunaga N; Kondo M; Yunoki K; Sakurai Y; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
    Anticancer Res; 2022 Oct; 42(10):4963-4971. PubMed ID: 36191973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, multicenter cohort study to validate a simple performance status-based survival prediction system for oncologists.
    Yamada T; Morita T; Maeda I; Inoue S; Ikenaga M; Matsumoto Y; Baba M; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Ono S; Ozawa T; Yamamoto R; Shishido H; Yamamoto N
    Cancer; 2017 Apr; 123(8):1442-1452. PubMed ID: 27926777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.